- decreased leukocyte cell number / IMPC
- abnormal heart morphology / IMPC
- enlarged heart / IMPC
- abnormal spleen morphology / IMPC
- enlarged spleen / IMPC
- abnormal uterus morphology / IMPC
- anophthalmia / IMPC
- decreased locomotor activity / IMPC
- decreased exploration in new environment / IMPC
- abnormal skin morphology / IMPC
- abnormal eye morphology / IMPC
- increased circulating alkaline phosphatase level / IMPC
- increased kidney weight / IMPC
- enlarged uterus / IMPC
- decreased lymphocyte cell number / IMPC
- increased cardiac muscle contractility / IMPC
- decreased CD8-positive, alpha-beta T cell number / IMPC
- enhanced cued conditioning behavior / IMPC
- decreased grip strength / IMPC
- dilated aorta / IMPC
- increased fasting circulating glucose level / IMPC
C57BL/6NCrl-Asb7em1(IMPC)Ccpcz/Ph
Status | Available to order |
EMMA ID | EM:12241 |
International strain name | C57BL/6NCrl-Asb7em1(IMPC)Ccpcz/Ph |
Alternative name | |
Strain type | Endonuclease-mediated |
Allele/Transgene symbol | Asb7em1(IMPC)Ccpcz |
Gene/Transgene symbol | Asb7 |
Information from provider
Provider | Institute of Molecular Genetics |
Provider affiliation | Department of Transgenic Models of Diseases, Institute of Molecular Genetics |
Genetic information | This mouse line originates from CRISPR zygote microinjection. For further details see the project page at the IMPC portal. |
Phenotypic information | Potential phenotyping data in the IMPC portal |
References | None available |
Information from EMMA
Archiving centre | Institute of Molecular Genetics, Prague, Czech Republic |
Animals used for archiving | heterozygous C57BL/6NCrl |
Disease and phenotype information
IMPC phenotypes (allele matching)
IMPC phenotypes (gene matching)
- decreased lymphocyte cell number / IMPC
- decreased grip strength / IMPC
- increased fasting circulating glucose level / IMPC
- abnormal heart morphology / IMPC
- abnormal eye morphology / IMPC
- increased circulating alkaline phosphatase level / IMPC
- anophthalmia / IMPC
- enlarged heart / IMPC
- abnormal spleen morphology / IMPC
- decreased locomotor activity / IMPC
- abnormal uterus morphology / IMPC
- increased cardiac muscle contractility / IMPC
- enlarged spleen / IMPC
- dilated aorta / IMPC
- decreased exploration in new environment / IMPC
- decreased leukocyte cell number / IMPC
- abnormal skin morphology / IMPC
- enhanced cued conditioning behavior / IMPC
- increased kidney weight / IMPC
- enlarged uterus / IMPC
- decreased CD8-positive, alpha-beta T cell number / IMPC
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).